Genelux Statistics
Total Valuation
Genelux has a market cap or net worth of $114.87 million. The enterprise value is $85.84 million.
Important Dates
The last earnings date was Friday, March 28, 2025, after market close.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genelux has 37.29 million shares outstanding. The number of shares has increased by 28.74% in one year.
| Current Share Class | 37.29M |
| Shares Outstanding | 37.29M |
| Shares Change (YoY) | +28.74% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 10.88% |
| Owned by Institutions (%) | 13.09% |
| Float | 30.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14,358.50 |
| Forward PS | n/a |
| PB Ratio | 3.14 |
| P/TBV Ratio | 4.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10,730.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.57 |
| Quick Ratio | 4.48 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -130.58% and return on invested capital (ROIC) is -79.03%.
| Return on Equity (ROE) | -130.58% |
| Return on Assets (ROA) | -63.28% |
| Return on Invested Capital (ROIC) | -79.03% |
| Return on Capital Employed (ROCE) | -113.96% |
| Revenue Per Employee | $348 |
| Profits Per Employee | -$1.30M |
| Employee Count | 23 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.84% in the last 52 weeks. The beta is -1.46, so Genelux's price volatility has been lower than the market average.
| Beta (5Y) | -1.46 |
| 52-Week Price Change | -48.84% |
| 50-Day Moving Average | 4.00 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 36.90 |
| Average Volume (20 Days) | 174,826 |
Short Selling Information
The latest short interest is 2.35 million, so 6.29% of the outstanding shares have been sold short.
| Short Interest | 2.35M |
| Short Previous Month | 2.45M |
| Short % of Shares Out | 6.29% |
| Short % of Float | 7.63% |
| Short Ratio (days to cover) | 13.52 |
Income Statement
In the last 12 months, Genelux had revenue of $8,000 and -$29.87 million in losses. Loss per share was -$0.95.
| Revenue | 8,000 |
| Gross Profit | 8,000 |
| Operating Income | -31.70M |
| Pretax Income | -25.78M |
| Net Income | -29.87M |
| EBITDA | -31.46M |
| EBIT | -31.70M |
| Loss Per Share | -$0.95 |
Full Income StatementBalance Sheet
The company has $30.90 million in cash and $1.87 million in debt, giving a net cash position of $29.03 million or $0.78 per share.
| Cash & Cash Equivalents | 30.90M |
| Total Debt | 1.87M |
| Net Cash | 29.03M |
| Net Cash Per Share | $0.78 |
| Equity (Book Value) | 26.27M |
| Book Value Per Share | 0.98 |
| Working Capital | 24.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$21.23 million and capital expenditures -$381,000, giving a free cash flow of -$21.61 million.
| Operating Cash Flow | -21.23M |
| Capital Expenditures | -381,000 |
| Free Cash Flow | -21.61M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -396,200.00% |
| Pretax Margin | -373,362.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |